This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Universitetet I Tromsø—norges Arktiske Universit. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Johannes Eksteen
Introduction
Johannes Eksteen is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of anti-lymphoma peptides. His work focuses on creating therapeutic agents that can combat tumors effectively.
Latest Patents
Johannes Eksteen holds a patent for his invention titled "Anti-lymphoma peptides." This invention provides a peptide that consists of 10 to 16 amino acids, featuring at least 8 cationic amino acids with specific side chains. The peptide also includes 2 or 3 tryptophan residues, which are strategically positioned. The invention extends to pharmaceutical compositions containing these peptides, emphasizing their use in therapy, especially as anti-tumor agents.
Career Highlights
Throughout his career, Johannes has been associated with prestigious institutions such as the University of Tromsø—Norwegian Arctic University. His research has contributed to advancements in therapeutic applications, particularly in oncology.
Collaborations
Johannes has collaborated with notable colleagues, including John Sigurd Svendsen and Øystein Rekdal. Their combined expertise has furthered the development of innovative solutions in the field of cancer treatment.
Conclusion
Johannes Eksteen's work exemplifies the impact of innovative research in biotechnology. His contributions to anti-lymphoma peptides highlight the potential for new therapeutic agents in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile